Kimihiro Shimatani
Papers
6
Total Citations
22
H-Index
3
About
Kimihiro Shimatani is a leading urologic surgeon and researcher whose work centers on optimizing outcomes in robot-assisted radical prostatectomy (RARP) for prostate cancer. His major contributions lie in clarifying how patient-specific factors and surgical techniques affect postoperative complications and oncological control. Notably, his 2024 study on thienopyridine-class antiplatelets demonstrated that these agents significantly increase bleeding risks during RARP, providing critical guidance for perioperative management. Another key paper revealed that aging independently elevates complication rates, helping surgeons better counsel older patients. Shimatani has also challenged surgical dogma: his 2025 reevaluation of extended lymph node dissection, drawing on over 8,000 patients, questions its therapeutic benefit in the modern robotic era. His work on neurovascular bundle preservation for high-risk cancer shows that nerve-sparing techniques can be safely employed without compromising biochemical recurrence outcomes. With several papers accumulating citations rapidly—including two with 7 citations each—Shimatani’s research is already shaping clinical practice. His investigations into neoadjuvant chemohormonal therapy for very high-risk disease further underscore his commitment to refining multimodal treatment strategies for aggressive prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6